Recently, our laboratory worked on the characterization of a third patient with SCPx deficiency, the first associated with a heterozygous mutation in SCP2, leading to low, but detectable levels of SCPx [125]. The gene discussed is SCP2; the disease is hyperinsulinemic hypoglycemia, familial, 4.